CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Net Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Block | ₹12,434 Cr | ₹9,895 Cr | ₹9,494 Cr | ₹9,101 Cr | ₹9,622 Cr |
What is the latest Net Block ratio of CIPLA ?
| Year | Net Block |
|---|---|
| Mar2026 | ₹12,434 Cr |
| Mar2025 | ₹9,895 Cr |
| Mar2024 | ₹9,494 Cr |
| Mar2023 | ₹9,101 Cr |
| Mar2022 | ₹9,622 Cr |
How is Net Block of CIPLA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,434 Cr | 25.66 | |
| Mar2025 | ₹9,895 Cr | 4.23 | |
| Mar2024 | ₹9,494 Cr | 4.32 | |
| Mar2023 | ₹9,101 Cr | -5.42 | |
| Mar2022 | ₹9,622 Cr | - | |
Compare Net Block of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,490.2 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,797.0 Cr | 8.1% | -2.2% | 1.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2% |
-0.2% |
-14.3% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses